about
Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and Onchocerciasis.Minocycline as a re-purposed anti-Wolbachia macrofilaricide: superiority compared with doxycycline regimens in a murine infection model of human lymphatic filariasis.Gastric expression of plasminogen activator inhibitor (PAI)-1 is associated with hyperphagia and obesity in micePlasminogen activator inhibitor (PAI)-1 suppresses inhibition of gastric emptying by cholecystokinin (CCK) in mice.Albendazole and antibiotics synergize to deliver short-course anti-Wolbachia curative treatments in preclinical models of filariasis.Validation of ultrasound bioimaging to predict worm burden and treatment efficacy in preclinical filariasis drug screening models.Boron-Pleuromutilins as Anti- Wolbachia Agents with Potential for Treatment of Onchocerciasis and Lymphatic Filariasis
P50
Q30377066-346C9BD0-5420-4887-BCF2-4A6DD5A4755BQ36708214-1C7B20E4-297B-4CBC-848E-C78775948B25Q37049096-2197BED3-6445-4DC0-8CAC-6737F25FFAC9Q42918870-E1906426-1CB9-4BF2-9814-BA13DD41400DQ44288385-F434BC76-187A-42A5-B494-662A200D9CB7Q54236651-F6A5A184-F675-42A2-8967-0B28DB9FB885Q64268314-A3CD320A-6797-436F-9350-5DD02E3C889D
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Joanne Gamble
@en
Joanne Gamble
@nl
type
label
Joanne Gamble
@en
Joanne Gamble
@nl
prefLabel
Joanne Gamble
@en
Joanne Gamble
@nl
P31
P496
0000-0001-7302-3412